XML 43 R32.htm IDEA: XBRL DOCUMENT v3.22.1
STOCK-BASED COMPENSATION PLAN (Tables)
 3 Months Ended
Mar. 31, 2022
Share-based Payment Arrangement [Abstract]  
Schedule of Share-based Payment Arrangement, Option, Activity
Stock option and RSU activity, prices, and values during the three months ended March 31, 2022 is as follows (in thousands, except for share, per share, and contractual term data):
Options OutstandingRSUs
Number of
shares		Weighted
average
exercise price		Weighted
average
remaining
 contractual
term
(years)		Aggregate
intrinsic
values
($'000s)		Number of plan shares outstandingWeighted average
grant date fair value
per Share
Balances as of December 31, 2021
3,796,530 $0.83 8.08$40,274 3,392,153 $10.69 
Options and RSUs granted65,717 8.00 2,150,859 5.46 
Options exercised and RSUs released(138,617)0.30 (873,070)11.12 
Options and RSUs forfeited(16,517)0.36 (35,974)10.15 
Balances as of March 31, 2022
3,707,113 $0.98 8.03$17,012 4,633,968 $8.82 
Options vested and exercisable - December 31, 2021
1,827,374 $0.31 7.20$20,337 
Options vested and exercisable - March 31, 2022
1,626,013 $0.56 7.41$8,140 
Schedule of Share-based Payment Arrangement, Restricted Stock Unit, Activity
Stock option and RSU activity, prices, and values during the three months ended March 31, 2022 is as follows (in thousands, except for share, per share, and contractual term data):
Options OutstandingRSUs
Number of
shares		Weighted
average
exercise price		Weighted
average
remaining
 contractual
term
(years)		Aggregate
intrinsic
values
($'000s)		Number of plan shares outstandingWeighted average
grant date fair value
per Share
Balances as of December 31, 2021
3,796,530 $0.83 8.08$40,274 3,392,153 $10.69 
Options and RSUs granted65,717 8.00 2,150,859 5.46 
Options exercised and RSUs released(138,617)0.30 (873,070)11.12 
Options and RSUs forfeited(16,517)0.36 (35,974)10.15 
Balances as of March 31, 2022
3,707,113 $0.98 8.03$17,012 4,633,968 $8.82 
Options vested and exercisable - December 31, 2021
1,827,374 $0.31 7.20$20,337 
Options vested and exercisable - March 31, 2022
1,626,013 $0.56 7.41$8,140 
Schedule of Valuation Assumptions
In accordance with ASC 718, Compensation – Stock Compensation, the fair value of each option grant has been estimated as of the date of grant using the following weighted average assumptions:
Three Months Ended March 31,
20222021
Risk-free rate1.64 %0.75 %
Expected dividends— — 
Expected term6 years6 years
Expected volatility73.95 %74.80 %
Schedule of Stock-Based Compensation The following table presents the amount of stock-based compensation related to stock-based awards to employees on the Company’s consolidated statements of operations and comprehensive loss (in thousands):
Three Months Ended March 31,
20222021
Research and development$587 $64 
Sales and marketing54 16 
General and administrative2,119 49 
Total stock-based compensation$2,760 $129